The WOMA Forum serves as a critical nexus for this synthesis. It is not merely a conference, but a convergence point for ...

"Through the integration of virtual control groups, EMA also seeks to improve the relevance and predictability of ...

Three behavioural phenomena are particularly consequential in screening and prevention research: ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

The FDA has ramped up the pressure on Amgen to withdraw Tavneos for a rare vasculitis condition from the market, with a ...

Mitapivat has been approved in the US under the Pyrukynd trade name since 2022 as a treatment for haemolytic anaemia in ...

In a new episode of the pharmaphorum podcast, recorded at BIO-Europe Spring in Lisbon, Portugal, web editor Nicole Raleigh ...

Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for cash ...

World Bipolar Day, which occurred 30 th March 2026, raises awareness and encourages better understanding of bipolar disorder, ...

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2 million people in order to reduce their risk of ...

Biogen is offering $41 per share for Apellis, with another $4 on offer if C3 inhibitor Syfovre (pegcetacoplan), approved by ...